Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Last updated: April 23, 2025
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting

Phase

N/A

Condition

Lung Disease

Treatment

Pneumonia

Healthy

ILD

Clinical Study ID

NCT03478826
17-008088
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited as a control group.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosisof pneumonia

  • Patients willing to provide written informed consent

Exclusion

Exclusion Criteria:

  • Unwillingness/unable to give blood samples

Study Design

Total Participants: 635
Treatment Group(s): 3
Primary Treatment: Pneumonia
Phase:
Study Start date:
August 01, 2018
Estimated Completion Date:
January 31, 2028

Study Description

The proposed biospecimen repository would be derived from patients diagnosed with ILD. This is to include 500 patients in the repository, with each patient contributing one blood sample. Patients with pneumonia and healthy patients will also be recruited as a control group.

Connect with a study center

  • Mayo Clinic

    Rochester, Minnesota 55905
    United States

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.